Osteoporosis Management Strategies (On Demand)
Activity approved for 1.0 ASRT Category A Credits
Activity approved for up to 1.0 AMA PRA Category 1 Credits™
Activity Expires July 1, 2024
This activity will describe the evidence behind optimal strategies in osteoporosis management, including optimal pharmacologic sequences and the role of combination therapy, as well as optimal treatment targets.
1. Describe various strategies in the longitudinal management of osteoporosis.
2. Identify optimal pharmacotherapeutic sequences for fracture risk reduction.
3. Discuss optimal targets in osteoporosis care.
Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.
On-Demand/ Enduring Material Cancellation Purchases of on-demand or enduring educational materials are non-refundable.
On-Demand/Enduring Material Program Changes or Cancellations ISCD reserves the right to cancel the program and/or change dates of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
ACCME Accreditation Statement
The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at firstname.lastname@example.org.
AMA PRA Category 1 Credit(s)™
The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.
ASRT Credit Designation
This activity has been approved by ASRT for 1.00 Category A continuing education credits.
Date of Original Release and most recent Review or Update
This activity was most recently reviewed and released on April 18, 2023, and will expire on July 1, 2024
Angela M. Cheung, MD, PhD, FRCPC
ISCD Canadian Panel Chair
University of Toronto, CANADA
Dr. Angela M. Cheung is Professor of Medicine, KY and Betty Ho Chair of Integrative Medicine at University of Toronto (UT) and Senior Physician Scientist at University Health Network (UHN). She is the Founding Director of University Health Network Osteoporosis Program and the Founding Director of University of Toronto Centre of Excellence in Skeletal Health Assessment (CESHA). She currently holds a Tier 1 Canada Research Chair in Musculoskeletal and Postmenopausal Health, and has held a Canadian Institutes of Health Research (CIHR) Senior Investigator award, the Canadian Society of Internal Medicine (CSIM) David Sackett Senior Investigator award, the Ontario Premier Research Award and the University of Toronto Eudenie Stuart Mentorship award and the Michael Hutcheon Mentor of the Year award. She is chair of the International Society of Clinical Densitometry Canadian Panel, member of International Osteoporosis Foundation Council of Scientific Advisors, member of Endocrine Society Clinical Guidelines Committee, and past chair of Osteoporosis Canada Scientific Advisory Council. She obtained her M.D. from Johns Hopkins University School of Medicine in 1988, and her PhD from Harvard University in 1997. She is a Fellow of the Royal College of Physicians of Canada and has been in clinical practice for >30 years.
Amgen (Self) : Advisory Board (Status: Ongoing); Paladin Labs Inc. (Self) : Advisory Board (Status: Ongoing)
Course Planners and Managers
Harold Rosen, MD, CCD - No Financial Relationships to Disclose
Fiore Barbini - No Financial Relationships to Disclose
Jill Seely, BS, CAHI, CMA - No Financial Relationships to Disclose
Course Content Reviewers
Wendy Tolman-Andrews - No Financial Relationships to Disclose
Angela M. Cheung, MD, PhD, FRCPC Disclosures: Amgen (Self) : Advisory Board (Status: Ongoing); Paladin Labs Inc. (Self) : Advisory Board (Status: Ongoing)
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendee Cancellation Policy
All changes in registration must be made in writing to email@example.com. Purchase of on-demand or enduring educational materials are non-refundable.
Course Changes or Cancellations
ISCD reserves the right to cancel the program and/or change dates of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.
|Access Date||Quiz Result||Score||Actions|